Phase-variable bacteria simultaneously express multiple capsules.

Samantha A Hsieh, David L Donermeyer, Stephen C Horvath, Paul M Allen
Author Information
  1. Samantha A Hsieh: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  2. David L Donermeyer: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  3. Stephen C Horvath: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  4. Paul M Allen: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Abstract

Capsular polysaccharides (CPSs) protect bacteria from host and environmental factors. Many bacteria can express different CPSs and these CPSs are phase variable. For example, ) is a prominent member of the human gut microbiome and expresses eight different capsular polysaccharides. Bacteria, including , have been shown to change their CPSs to adapt to various niches such as immune, bacteriophage, and antibiotic perturbations. However, there are limited tools to study CPSs and fundamental questions regarding phase variance, including if gut bacteria can express more than one capsule at the same time, remain unanswered. To better understand the roles of different CPSs, we generated a CPS1-specific antibody and a flow cytometry assay to detect CPS expression in individual bacteria in the gut microbiota. Using these novel tools, we report for the first time that bacteria can simultaneously express multiple CPSs. We also observed that nutrients such as glucose and salts had no effect on CPS expression. The ability to express multiple CPSs at the same time may provide bacteria with an adaptive advantage to thrive amid changing host and environmental conditions, especially in the intestine.

Keywords

References

  1. Mol Microbiol. 1996 Jun;20(6):1211-20 [PMID: 8809773]
  2. Infection. 1984;12 Suppl 1:S72-7 [PMID: 6442282]
  3. Appl Environ Microbiol. 2011 Feb;77(3):954-65 [PMID: 21131523]
  4. Microbiol Mol Biol Rev. 2006 Mar;70(1):157-76 [PMID: 16524921]
  5. Methods Mol Biol. 2019;1969:217-236 [PMID: 30877680]
  6. Sci Immunol. 2019 Feb 8;4(32): [PMID: 30737355]
  7. Environ Microbiol. 2011 Mar;13(3):643-54 [PMID: 21059165]
  8. Biotechnol Bioeng. 2014 Jan;111(1):165-73 [PMID: 23996813]
  9. Microbiology (Reading). 2003 Feb;149(Pt 2):497-504 [PMID: 12624211]
  10. Cell Host Microbe. 2017 Oct 11;22(4):494-506.e8 [PMID: 28966055]
  11. Nat Microbiol. 2020 Sep;5(9):1170-1181 [PMID: 32601452]
  12. Trends Microbiol. 2018 Nov;26(11):966-967 [PMID: 30193959]
  13. Environ Microbiol. 2009 Aug;11(8):1934-44 [PMID: 19689704]
  14. Front Immunol. 2020 Apr 15;11:690 [PMID: 32351514]
  15. J Biol Chem. 2015 May 15;290(20):12630-49 [PMID: 25795776]
  16. Cell Host Microbe. 2020 Sep 9;28(3):371-379.e5 [PMID: 32652063]
  17. Annu Rev Microbiol. 2017 Sep 8;71:349-369 [PMID: 28657886]
  18. J Infect Dis. 2004 Jan 15;189(2):328-38 [PMID: 14722899]
  19. Cell Host Microbe. 2015 May 13;17(5):672-80 [PMID: 25974305]
  20. Science. 2003 Mar 28;299(5615):2074-6 [PMID: 12663928]
  21. Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10446-51 [PMID: 12915735]
  22. Environ Microbiol Rep. 2015 Oct;7(5):789-94 [PMID: 26147440]
  23. Science. 2005 Mar 18;307(5716):1778-81 [PMID: 15774760]
  24. J Immunol. 2020 Feb 15;204(4):1035-1046 [PMID: 31900343]
  25. Front Cell Infect Microbiol. 2012 Feb 20;2:11 [PMID: 22919603]
  26. Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11976-80 [PMID: 20547868]
  27. J Immunol. 1979 Oct;123(4):1548-50 [PMID: 113458]
  28. Science. 2005 Mar 25;307(5717):1955-9 [PMID: 15790854]
  29. J Biol Chem. 2006 Nov 24;281(47):36269-79 [PMID: 16968696]
  30. Infect Immun. 2001 Nov;69(11):6893-901 [PMID: 11598064]
  31. PLoS Med. 2008 Mar 4;5(3):e41 [PMID: 18318596]
  32. Drug Discov Today Technol. 2020 Dec;35-36:23-33 [PMID: 33388125]
  33. Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8834-9 [PMID: 16735464]
  34. Infect Immun. 1999 May;67(5):2250-7 [PMID: 10225881]
  35. J Bacteriol. 2009 Dec;191(23):7288-95 [PMID: 19801412]
  36. J Biol Chem. 2009 Jul 3;284(27):18445-57 [PMID: 19403529]
  37. Microbiol Spectr. 2019 Jan;7(1): [PMID: 30737916]

Grants

  1. F30 DK114950/NIDDK NIH HHS
  2. R21 AI142257/NIAID NIH HHS

MeSH Term

Bacterial Capsules
Bacteroides thetaiotaomicron
Gastrointestinal Microbiome
Humans
Polysaccharides, Bacterial

Chemicals

Polysaccharides, Bacterial

Word Cloud

Created with Highcharts 10.0.0CPSsbacteriaexpresscandifferentguttimemultiplepolysaccharideshostenvironmentalphasemicrobiomecapsularincludingtoolsCPSexpressionsimultaneouslyCapsularprotectfactorsManyvariableexampleprominentmemberhumanexpresseseightBacteriashownchangeadaptvariousnichesimmunebacteriophageantibioticperturbationsHoweverlimitedstudyfundamentalquestionsregardingvarianceonecapsuleremainunansweredbetterunderstandrolesgeneratedCPS1-specificantibodyflowcytometryassaydetectindividualmicrobiotaUsingnovelreportfirstalsoobservednutrientsglucosesaltseffectabilitymayprovideadaptiveadvantagethriveamidchangingconditionsespeciallyintestinePhase-variablecapsulespolysaccharidephase-variable

Similar Articles

Cited By